Aprovel



Combined with:

Indications and Reactions:

Role Indications Reactions
Primary
Hypertension 56.2%
Diabetes Mellitus 4.9%
Drug Use For Unknown Indication 3.9%
Renal Impairment 3.9%
Essential Hypertension 3.4%
Myocardial Ischaemia 3.0%
Renal Disorder 3.0%
Depression 2.5%
Product Used For Unknown Indication 2.5%
Alcohol Problem 2.0%
Atrial Fibrillation 2.0%
Epilepsy 2.0%
Prophylaxis 2.0%
Anxiety 1.5%
Dermatomyositis 1.5%
Pain 1.5%
Thrombosis Prophylaxis 1.5%
Back Pain 1.0%
Blood Pressure 1.0%
Cerebrovascular Accident 1.0%
Renal Failure Acute 13.0%
Hyponatraemia 11.1%
Pregnancy 7.4%
Renal Cell Carcinoma Stage Unspecified 7.4%
Visual Acuity Reduced 5.6%
Anaphylactic Shock 3.7%
Cardio-respiratory Arrest 3.7%
Cataract 3.7%
Drug Rash With Eosinophilia And Systemic Symptoms 3.7%
Fall 3.7%
Hyperkalaemia 3.7%
Hypertension 3.7%
Malaise 3.7%
Myalgia 3.7%
Nightmare 3.7%
Pancreatitis Acute 3.7%
Psoriasis 3.7%
Retinal Disorder 3.7%
Rhabdomyolysis 3.7%
Shock 3.7%
Secondary
Drug Use For Unknown Indication 25.0%
Hypertension 23.0%
Product Used For Unknown Indication 22.3%
Depression 3.5%
Type 2 Diabetes Mellitus 3.5%
Diabetes Mellitus 2.7%
Rheumatoid Arthritis 2.6%
Pain 2.0%
Tooth Disorder 2.0%
Essential Hypertension 1.9%
Prophylaxis 1.6%
Atrial Fibrillation 1.3%
Benign Prostatic Hyperplasia 1.3%
Hypercholesterolaemia 1.3%
Chest Pain 1.2%
Renal Impairment 1.2%
Osteoporosis 1.0%
Thrombosis Prophylaxis 1.0%
Cerebrovascular Accident 0.9%
Constipation 0.9%
Renal Failure Acute 27.9%
Renal Failure 9.0%
Rhabdomyolysis 7.4%
Visual Impairment 5.7%
Hepatitis 4.9%
Memory Impairment 4.9%
Leukocytosis 4.1%
Cataract 3.3%
Hyponatraemia 3.3%
Presyncope 3.3%
Urinary Retention 3.3%
Weight Decreased 3.3%
Coronary Artery Bypass 2.5%
Cytolytic Hepatitis 2.5%
Dermatitis Exfoliative 2.5%
Diarrhoea 2.5%
Nausea 2.5%
Osteonecrosis 2.5%
Ovarian Cancer 2.5%
Prothrombin Time Ratio Decreased 2.5%
Concomitant
Hypertension 23.1%
Drug Use For Unknown Indication 17.0%
Product Used For Unknown Indication 16.2%
Diabetes Mellitus 5.7%
Rheumatoid Arthritis 5.6%
Pain 3.7%
Type 2 Diabetes Mellitus 3.5%
Atrial Fibrillation 3.0%
Prophylaxis 2.7%
Osteoporosis 2.6%
Depression 2.6%
Hypercholesterolaemia 2.5%
Thrombosis Prophylaxis 1.8%
Unevaluable Event 1.7%
Essential Hypertension 1.6%
Hepatitis C 1.5%
Anaesthesia 1.4%
Sepsis 1.3%
Renal Cell Carcinoma 1.3%
Nausea 1.2%
Thrombocytopenia 9.5%
Vomiting 9.5%
Weight Decreased 8.9%
Renal Failure 8.3%
Renal Failure Acute 8.0%
Pyrexia 7.1%
Toxic Skin Eruption 5.3%
Pulmonary Embolism 5.0%
Myocardial Infarction 4.7%
Urinary Tract Infection 4.5%
Weight Increased 3.6%
Pneumonia 3.3%
Vertigo 3.3%
Atrial Fibrillation 3.0%
Hepatocellular Injury 3.0%
Somnolence 3.0%
International Normalised Ratio Increased 2.7%
Systemic Lupus Erythematosus 2.7%
Hypertensive Encephalopathy 2.4%
Hypoglycaemia 2.4%
Interacting
Hypertension 24.0%
Drug Use For Unknown Indication 22.0%
Product Used For Unknown Indication 22.0%
Diabetes Mellitus 10.0%
Bronchitis 4.0%
Arrhythmia 2.0%
Arthralgia 2.0%
Computerised Tomogram 2.0%
Diabetes Mellitus Non-insulin-dependent 2.0%
Epilepsy 2.0%
Fungal Infection 2.0%
Insulin-requiring Type 2 Diabetes Mellitus 2.0%
Osteoarthritis 2.0%
Thrombosis Prophylaxis 2.0%
Renal Failure Acute 35.7%
Hyperkalaemia 14.3%
Vomiting 14.3%
International Normalised Ratio Increased 7.1%
Overdose 7.1%
Psoriasis 7.1%
Renal Failure Chronic 7.1%
Total Lung Capacity Decreased 7.1%